Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-08-09
1993-04-20
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514408, 514835, A61N 31495, A61N 3140
Patent
active
052043509
ABSTRACT:
Compounds of the general formula ##STR1## Y is an integer of from 0 to 6 is chosen from: O,
REFERENCES:
Journal of Cell Biology, vol. 111 (1990) by Sato, et al.
Journal of Bone and Mineral Research, vol. 5 No. 1, pp. 31-40 (1990), Sato et al.
Bone, 9 73-79 (1988), Kanasha, et al.
Egbertson Melissa S.
Gould Robert J.
Hartman George D.
Caruso Charles M.
Criares T. J.
Grassler Frank P.
Merck & Co. , Inc.
Parr Richard S.
LandOfFree
Method of inhibiting osteoclast-mediated bone resorption by admi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting osteoclast-mediated bone resorption by admi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting osteoclast-mediated bone resorption by admi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1526296